Author Archives: davidrcurry

Gender-based violence experiences among Palestinian women during the COVID-19 pandemic: mental health professionals’ perceptions and concerns

Posted on by

Conflict and Health
http://www.conflictandhealth.com/
[Accessed 09 Apr 2022]

 

Gender-based violence experiences among Palestinian women during the COVID-19 pandemic: mental health professionals’ perceptions and concerns
Authors: Fayez Mahamid, Guido Veronese and Dana Bdier
Content type: Research 4 April 2022

Science in times of war: oppose Russian aggression but support Russian scientists

Posted on by

EMBO Reports
Volume 23 Issue 4 5 April 2022
https://www.embopress.org/toc/14693178/current

 

Opinion 15 March 2022 Free Access
Science in times of war: oppose Russian aggression but support Russian scientists
Eugene V Koonin
In the face of Russia’s invasion of the Ukraine, the global scientific community must continue to support their Russian colleagues without endorsing their government.
Science & Society23 February 2022 Open Access

Science in times of war: oppose Russian aggression but support Russian scientists

Posted on by

EMBO Reports
Volume 23 Issue 4 5 April 2022
https://www.embopress.org/toc/14693178/current

 

Opinion 15 March 2022 Free Access
Science in times of war: oppose Russian aggression but support Russian scientists
Eugene V Koonin
In the face of Russia’s invasion of the Ukraine, the global scientific community must continue to support their Russian colleagues without endorsing their government.
Science & Society23 February 2022 Open Access

Lamarck redux and other false arguments against SARS-CoV-2 vaccination: Pseudoscientific arguments against vaccination do not stand up to scrutiny

Posted on by

EMBO Reports
Volume 23 Issue 4 5 April 2022
https://www.embopress.org/toc/14693178/current

Lamarck redux and other false arguments against SARS-CoV-2 vaccination: Pseudoscientific arguments against vaccination do not stand up to scrutiny
Emanuel Goldman

 

The COVID-19 pandemic has triggered a new bout of anti-vaccination propaganda. These are often grounded in pseudoscience and misinterpretation of evolutionary biology.

Effect of Sotrovimab on Hospitalization or Death Among High-risk Patients With Mild to Moderate COVID-19A Randomized Clinical Trial

Posted on by

JAMA
April 5, 2022, Vol 327, No. 13, Pages 1209-1300
https://jamanetwork.com/journals/jama/currentissue

 

Original Investigation
Effect of Sotrovimab on Hospitalization or Death Among High-risk Patients With Mild to Moderate COVID-19A Randomized Clinical Trial
Anil Gupta, MD; Yaneicy Gonzalez-Rojas, MD; Erick Juarez, MD; et al.
free access has active quiz
JAMA. 2022;327(13):1236-1246. doi:10.1001/jama.2022.2832
This randomized clinical trial compares the efficacy and adverse events of sotrovimab vs placebo in preventing progression of mild to moderate COVID-19 to severe disease.

Effect of Antiplatelet Therapy on Survival and Organ Support–Free Days in Critically Ill Patients With COVID-19A Randomized Clinical Trial

Posted on by

JAMA
April 5, 2022, Vol 327, No. 13, Pages 1209-1300
https://jamanetwork.com/journals/jama/currentissue

 

Caring for the Critically Ill Patient
Effect of Antiplatelet Therapy on Survival and Organ Support–Free Days in Critically Ill Patients With COVID-19A Randomized Clinical Trial
REMAP-CAP Writing Committee for the REMAP-CAP Investigators
free access has active quiz
JAMA. 2022;327(13):1247-1259. doi:10.1001/jama.2022.2910
This randomized clinical trial assesses the effect of treatment with an antiplatelet agent vs no antiplatelet therapy on days alive and free of intensive care unit respiratory or cardiovascular organ support within 21 days among patients critically ill with COVID-19.

Association Between 2-Dose vs 3-Dose Hepatitis B Vaccine and Acute Myocardial Infarction

Posted on by

JAMA
April 5, 2022, Vol 327, No. 13, Pages 1209-1300
https://jamanetwork.com/journals/jama/currentissue

 

Association Between 2-Dose vs 3-Dose Hepatitis B Vaccine and Acute Myocardial Infarction
Katia Bruxvoort, PhD; Jeff Slezak, MS; Lei Qian, PhD; et al.
free access
JAMA. 2022;327(13):1260-1268. doi:10.1001/jama.2022.2540
This large prospective cohort study compares the rates of acute myocardial infarction between recipients of a 2-dose hepatitis B vaccine and recipients of a 3-dose hepatitis B vaccine.

Estimates of SARS-CoV-2 Omicron Variant Severity in Ontario, Canada

Posted on by

JAMA
April 5, 2022, Vol 327, No. 13, Pages 1209-1300
https://jamanetwork.com/journals/jama/currentissue

 

Research Letter
Estimates of SARS-CoV-2 Omicron Variant Severity in Ontario, Canada
Ana Cecilia Ulloa, MPH; Sarah A. Buchan, PhD; Nick Daneman, MD, MSc; et al.
free access has active quiz has audio
JAMA. 2022;327(13):1286-1288. doi:10.1001/jama.2022.2274
This study examines hospitalizations and deaths associated with the SARS-CoV-2 Omicron variant compared with matched patients infected with the Delta variant.

Expanding Efforts and Support to Respond to the HIV and COVID-19 Intersecting Pandemics

Posted on by

JAMA
April 5, 2022, Vol 327, No. 13, Pages 1209-1300
https://jamanetwork.com/journals/jama/currentissue

 

Viewpoint
Expanding Efforts and Support to Respond to the HIV and COVID-19 Intersecting Pandemics
Lawrence Corey, MD; Russell Corbett-Detig, PhD; Chris Beyrer, MD, MPH
free access
JAMA. 2022;327(13):1227-1228. doi:10.1001/jama.2022.3517
This Viewpoint discusses the generation of SARS-CoV-2 variants of concern globally and the need for increased access to COVID-19 vaccination in Africa, particularly for people living with HIV and for households and people living in densely populated communities.

The potential of mitochondrial genome engineering

Posted on by

Nature Reviews Genetics
Volume 23 Issue 4, April 2022
https://www.nature.com/nrg/volumes/23/issues/4

 

Review Article | 02 December 2021
The potential of mitochondrial genome engineering
The authors review the field of mammalian mitochondrial genome engineering, culminating in the recent development of mitochondrially targeted programmable nucleases and base editors. They describe research that led to the development of animal models of mitochondrial disease, as well as the potential for translating these approaches to the clinic.
Pedro Silva-Pinheiro, Michal Minczuk

Lessons from Long COVID: working with patients to design better research

Posted on by

Nature Reviews Immunology
Volume 22 Issue 4, April 2022
https://www.nature.com/nri/volumes/22/issues/4

 

Comment | 15 February 2022
Lessons from Long COVID: working with patients to design better research
In this Comment article, Nisreen Alwan discusses what her experience as both a public health academic and a person living with Long COVID has taught her about the importance of including those with lived experience of a condition in setting the research agenda.
Nisreen A. Alwan

Vaccine safety in an era of novel vaccines: a proposed research agenda

Posted on by

Nature Reviews Immunology
Volume 22 Issue 4, April 2022
https://www.nature.com/nri/volumes/22/issues/4

 

Collection: COVID-19 Watch
Comment | 23 February 2022
Vaccine safety in an era of novel vaccines: a proposed research agenda
In this Comment article, Gregory Poland and Richard Kennedy outline the importance of continued funding and infrastructure support for research into vaccine safety to inform public health decisions and increase public trust in new vaccine technologies.
Gregory A. Poland
Richard B. Kennedy

Mucosal vaccines — fortifying the frontiers

Posted on by

Nature Reviews Immunology
Volume 22 Issue 4, April 2022
https://www.nature.com/nri/volumes/22/issues/4

 

Review Article | 26 July 2021
Mucosal vaccines — fortifying the frontiers
Here, Ed Lavelle and Ross Ward discuss the unique aspects of mucosal immunity that must be considered when developing effective mucosal vaccines. The authors highlight the key immune cell populations that are targeted by mucosal vaccination strategies and explain how innovative adjuvant and delivery approaches should lead to new vaccines for infectious diseases and cancers.
Ed C. Lavelle
Ross W. Ward

Identification of neoantigens for individualized therapeutic cancer vaccines

Posted on by

Nature Reviews Drug Discovery
Volume 21 Issue 4, April 2022
https://www.nature.com/nrd/volumes/21/issues/4

 

Review Article | 01 February 2022
Identification of neoantigens for individualized therapeutic cancer vaccines
Mutations in cancer cells can generate tumour-specific neoepitopes, which are attractive targets for anticancer vaccines. This Review discusses the mechanisms of neoantigen T cell recognition and computational approaches to predict which neoantigens might confer proficient antitumour immunity in a given clinical context.
Franziska Lang, Barbara Schrörs, Ugur Sahin

Population Immunity and Covid-19 Severity with Omicron Variant in South Africa

Posted on by

New England Journal of Medicine
April 7, 2022 Vol. 386 No. 14
https://www.nejm.org/toc/nejm/medical-journal

 

Original Articles
Population Immunity and Covid-19 Severity with Omicron Variant in South Africa S.A. Madhi and Others
Widespread underlying SARS-CoV-2 seropositivity was observed in Gauteng before the omicron-dominant wave of Covid-19. Epidemiologic data showed a decoupling of hospitalizations and deaths from infections while omicron was circulating.

Prenatal influenza vaccination and allergic and autoimmune diseases in childhood: A longitudinal, population-based linked cohort study

Posted on by

PLoS Medicine
http://www.plosmedicine.org/
(Accessed 09 Apr 2022)

 

Prenatal influenza vaccination and allergic and autoimmune diseases in childhood: A longitudinal, population-based linked cohort study
Damien Foo, Mohinder Sarna, Gavin Pereira, Hannah C. Moore, Annette K. Regan
Research Article | published 05 Apr 2022 PLOS Medicine
https://doi.org/10.1371/journal.pmed.1003963

Awareness, attitudes and acceptability of the HPV vaccine among female university students in Morocco

Posted on by

PLoS One
http://www.plosone.org/
[Accessed 09 Apr 2022]

 

Awareness, attitudes and acceptability of the HPV vaccine among female university students in Morocco
A. Yacouti, N. Elkhoudri, A. El got, A. Benider, F. Hadrya, R. Baddou, A. Forster, M. Mouallif
Research Article | published 08 Apr 2022 PLOS ONE
https://doi.org/10.1371/journal.pone.0266081

COVID-19 vaccine acceptance, hesitancy, and associated factors among medical students in Sudan

Posted on by

PLoS One
http://www.plosone.org/
[Accessed 09 Apr 2022]

 

COVID-19 vaccine acceptance, hesitancy, and associated factors among medical students in Sudan
Saud Mohammed Raja, Murwan Eissa Osman, Abdelmageed Osman Musa, Asim Abdelmoneim Hussien, Kabirat Yusuf
Research Article | published 07 Apr 2022 PLOS ONE
https://doi.org/10.1371/journal.pone.0266670

The COVID-19 Vaccine: Trust, doubt, and hope for a future beyond the pandemic in Germany

Posted on by

PLoS One
http://www.plosone.org/
[Accessed 09 Apr 2022]

 

The COVID-19 Vaccine: Trust, doubt, and hope for a future beyond the pandemic in Germany
Amelia Fiske, Franziska Schönweitz, Johanna Eichinger, Bettina Zimmermann, Nora Hangel, Anna Sierawska, Stuart McLennan, Alena Buyx
Research Article | published 07 Apr 2022 PLOS ONE
https://doi.org/10.1371/journal.pone.0266659

Knowledge, attitude, and practice of seasonal influenza and influenza vaccine immunization among people visiting primary healthcare centers in Riyadh, Saudi Arabia

Posted on by

PLoS One
http://www.plosone.org/
[Accessed 09 Apr 2022]

 

Knowledge, attitude, and practice of seasonal influenza and influenza vaccine immunization among people visiting primary healthcare centers in Riyadh, Saudi Arabia
Norah Alhatim, Ahmad M. Al-Bashaireh, Ola Alqudah
Research Article | published 04 Apr 2022 PLOS ONE
https://doi.org/10.1371/journal.pone.0266440

A single-shot vaccine approach for the universal influenza A vaccine candidate M2e

Posted on by

PNAS – Proceedings of the National Academy of Sciences of the United States
March 29, 2022 | vol. 119 | no. 13
https://www.pnas.org/toc/pnas/119/13

 

Research Article
March 23, 2022
A single-shot vaccine approach for the universal influenza A vaccine candidate M2e
Influenza, commonly referred to as “flu,” is a major global public health concern and a huge economic burden to societies. Current influenza vaccines need to be updated annually to match circulating strains, resulting in low take-up rates and poor …
Ranmali Kavishna, Tha Yang Kang, […] Sylvie Alonso

The Serbian COVID-19 Stress Scale and vaccine acceptance: is there a place for COVID-19-related distress in explaining attitudes towards vaccination?

Posted on by

Public Health
Volume 205 Pages e1-e30, 1-216 (April 2022)
https://www.sciencedirect.com/journal/public-health/vol/205/suppl/C

 

Research article Full text access
The Serbian COVID-19 Stress Scale and vaccine acceptance: is there a place for COVID-19-related distress in explaining attitudes towards vaccination?
L. Mihić, Z. Terzić-Šupić, J. Todorović, N.P. Marić
Pages 37-42

Building the concept for WHO Evidence Considerations for Vaccine Policy (ECVP): Tuberculosis vaccines intended for adults and adolescents as a test case

Posted on by

Vaccine
Volume 40, Issue 12 Pages 1681-1912 (15 March 2022)
https://www.sciencedirect.com/journal/vaccine/vol/40/issue/12

 

Conference info Open access
Building the concept for WHO Evidence Considerations for Vaccine Policy (ECVP): Tuberculosis vaccines intended for adults and adolescents as a test case
Sonali Kochhar, Draurio Barreira, Pauline Beattie, Marco Cavaleri, … Birgitte Giersing
Pages 1681-1690

Projecting the cost of introducing typhoid conjugate vaccine (TCV) in the national immunization program in Malawi using a standardized costing framework

Posted on by

Vaccine
Volume 40, Issue 12 Pages 1681-1912 (15 March 2022)
https://www.sciencedirect.com/journal/vaccine/vol/40/issue/12

 

Research article Open access
Projecting the cost of introducing typhoid conjugate vaccine (TCV) in the national immunization program in Malawi using a standardized costing framework
Frédéric Debellut, Rouden Mkisi, Vincent Masoo, Mike Chisema, … Clint Pecenka
Pages 1741-1746

Impact of the COVID-19 pandemic on routine immunization coverage in children under 2 years old in Ontario, Canada: A retrospective cohort study

Posted on by

Vaccine
Volume 40, Issue 12 Pages 1681-1912 (15 March 2022)
https://www.sciencedirect.com/journal/vaccine/vol/40/issue/12

 

Research article Open access
Impact of the COVID-19 pandemic on routine immunization coverage in children under 2 years old in Ontario, Canada: A retrospective cohort study
Catherine Ji, Pierre-Philippe Piché-Renaud, Jemisha Apajee, Ellen Stephenson, … Karen Tu
Pages 1790-1798

Exploring the attitudes, concerns, and knowledge regarding COVID-19 vaccine by the parents of children with rheumatic disease: Cross-sectional online survey

Posted on by

Vaccine
Volume 40, Issue 12 Pages 1681-1912 (15 March 2022)
https://www.sciencedirect.com/journal/vaccine/vol/40/issue/12

 

Research article Full text access
Exploring the attitudes, concerns, and knowledge regarding COVID-19 vaccine by the parents of children with rheumatic disease: Cross-sectional online survey
Özlem Akgün, Gülşah Kavrul Kayaalp, Fatma Gül Demirkan, Figen Çakmak, … Nuray Aktay Ayaz
Pages 1829-1836

The role of perceived social norms in college student vaccine hesitancy: Implications for COVID-19 prevention strategies

Posted on by

Vaccine
Volume 40, Issue 12 Pages 1681-1912 (15 March 2022)
https://www.sciencedirect.com/journal/vaccine/vol/40/issue/12

 

Research article Full text access
The role of perceived social norms in college student vaccine hesitancy: Implications for COVID-19 prevention strategies
Anna E. Jaffe, Scott Graupensperger, Jessica A. Blayney, Jennifer C. Duckworth, Cynthia A. Stappenbeck
Pages 1888-1895